CASRAI Dictionary

Tag: ai in research administration

  • AI Legislation Tracker: Free Tools Compared for Research Offices

    An AI legislation tracker is a curated, continuously updated resource that monitors the progress of artificial intelligence bills, statutes and regulations across jurisdictions. For research offices, three free options cover the ground a paid GRC subscription would otherwise charge for: the IAPP’s US State AI Governance Legislation Tracker for state-level bills, White & Case’s AI Watch for a global regulatory sweep, and the AI Act Explorer for line-by-line navigation of the EU AI Act. Used together, they give research administrators enough coverage to flag compliance and procurement risk without a dedicated legal-intelligence budget.

    An AI legislation tracker is a legal-intelligence tool — usually maintained by a law firm, professional association, or legislature — that indexes AI-related bills and regulations by jurisdiction, status and topic so non-specialists can monitor change without reading primary legislative text. For a research office, that means catching a new state disclosure requirement or an EU AI Act compliance deadline before it lands in an audit finding.

    Table of contents

    What is an AI legislation tracker, and why does a research office need one?

    Research offices sit at the intersection of three regulatory pressures: institutional AI-use policy, funder terms and conditions, and the AI laws of every jurisdiction in which their institution operates, procures software or receives funding. No single regulator publishes a consolidated feed of all three, which is why legal-intelligence trackers — built by law firms and associations to serve their own clients — have become the de facto public monitoring layer for everyone else.

    Three gaps make this monitoring hard for a research office specifically. First, state-level fragmentation in the US: MultiState.ai reported tracking 1,561 AI-related bills across 45 states in early 2026, and a bill’s status can change between a legislative session’s opening and a grant’s renewal date. Second, phased EU obligations: the AI Act (Regulation (EU) 2024/1689) entered into force on 1 August 2024 but applies in stages — prohibited-practice provisions since 2 February 2025, general-purpose AI model obligations since 2 August 2025, and the bulk of high-risk system obligations from 2 August 2026. Third, procurement-clause drift: institutional purchasing teams increasingly need to know whether a vendor’s AI tool falls under a “high-risk” classification before a contract is signed, not after.

    Comparing the free trackers: IAPP, White & Case AI Watch and the AI Act Explorer

    Each of the three core tools covers a different layer of the regulatory stack. None requires a paid subscription for the baseline tracker view, though firms use them as client-development tools, so update cadence and depth of legal commentary vary.

    Tool Publisher Geographic scope Best use for a research office Cost
    US State AI Governance Legislation Tracker IAPP US state legislatures Flagging new state disclosure/consumer-protection bills affecting AI-assisted research tools Free
    AI Watch: Global Regulatory Tracker White & Case US, EU, UK, China and other core markets Cross-jurisdiction horizon-scanning for institutions with international partners Free
    AI Act Explorer Future of Life Institute (artificialintelligenceact.eu) European Union Locating the exact article/annex governing a specific AI use case before procurement sign-off Free
    Artificial Intelligence Legislation Database National Conference of State Legislatures (NCSL) US state legislatures Official-source cross-check against law-firm trackers, filterable by policy topic Free
    OECD.AI Policy Navigator OECD 80+ countries and international bodies Global baseline for institutions with funders or partners outside the US/EU Free

    Two law-firm trackers rarely agree exactly on bill status, since each applies its own inclusion criteria — the IAPP chart, for example, deliberately excludes government-only AI bills to focus on rules affecting private-sector organisations. A research office should treat the NCSL database as the authoritative cross-check whenever a law-firm tracker and an internal compliance log disagree, since NCSL draws directly from legislative records rather than curated commentary.

    How to monitor AI law without a paid GRC subscription

    A practical monitoring routine needs three components: a jurisdiction list, a check cadence, and an escalation trigger. Map the institution’s actual footprint — states where staff or partner sites are located, countries with active funder relationships, and any EU-based collaborators — against the five tools above, rather than trying to watch all 45+ US states with active bills at once.

    • Set a monthly review of the IAPP tracker and NCSL database for the institution’s home state plus any state with a satellite campus or major subcontractor.
    • Set a quarterly review of White & Case AI Watch for jurisdictions tied to international grant or publishing partners.
    • Check the AI Act Explorer whenever procuring or renewing an AI-enabled research tool from an EU-based or EU-selling vendor, since Article 53 transparency obligations for general-purpose AI providers already apply.
    • Escalate to institutional counsel the moment a tracked bill moves from “introduced” to “enacted” in a jurisdiction on the footprint list — status changes, not initial filings, are the actionable signal.

    This cadence substitutes staff time for the subscription cost of a commercial GRC platform. It will not catch everything a paid legal-intelligence service would, but it closes the gap between “no monitoring” and “monitoring proportionate to institutional risk,” which is the realistic target for most research offices.

    Which AI rules actually affect grant compliance and procurement

    Not every tracked bill is relevant to a research office. The ones that matter cluster into two categories: funder-facing disclosure requirements and vendor/procurement obligations. On the funder side, publishers already require disclosure of generative-AI use in manuscript preparation under guidance from bodies such as ICMJE and COPE — a policy layer that sits alongside, not inside, the legislative trackers above, and one research offices should monitor through authorship policy channels rather than a legislation tracker.

    On the procurement side, the EU AI Act’s general-purpose AI model obligations — applicable since 2 August 2025 — require providers to maintain technical documentation and, for systemic-risk models, conduct model evaluations; institutions procuring AI research tools from in-scope vendors should expect updated contract terms reflecting this. Separately, under Article 57 of Regulation (EU) 2024/1689, each EU member state must establish at least one national AI regulatory sandbox operational by 2 August 2026 — a detail the AI Act Explorer surfaces clearly but general news coverage rarely mentions, and one that matters to institutions running EU-based pilot deployments of AI research tools.

    In the US, state consumer-protection style AI bills increasingly impose obligations on “deployers” as well as developers — meaning an institution using a third-party AI tool, not just the vendor that built it, can carry compliance obligations. This is the single most consequential fact a research office should extract from the state trackers: deployer obligations mean procurement due diligence, not just vendor selection, is now a compliance function.

    Common questions research administrators ask

    Are there any regulations on AI?

    Yes. There is no comprehensive federal AI statute in the United States, but individual US states have enacted targeted laws, the European Union’s AI Act (Regulation (EU) 2024/1689) is in force with phased obligations through 2027, and dozens of other jurisdictions maintain sector-specific or principles-based AI policy frameworks tracked by the OECD.

    Does Europe have AI regulations?

    Yes. The EU AI Act is the first comprehensive AI-specific legal framework, entering into force on 1 August 2024. Prohibited-practice rules applied from February 2025, general-purpose AI model obligations from August 2025, and most high-risk system requirements apply from August 2026 onward.

    Where are the AI regulations?

    AI rules are distributed across national statutes, EU regulation, and US state legislatures rather than one source — which is precisely why trackers such as IAPP’s state chart, White & Case’s AI Watch, and the AI Act Explorer exist: each consolidates one layer of a fragmented, multi-jurisdiction landscape into a single reference point.

    The regulatory landscape a research office must monitor will keep expanding rather than consolidating: more US states are expected to move bills from “introduced” to “enacted” through 2026 and 2027, and the EU AI Act’s remaining compliance deadlines run to August 2027. A footprint-mapped, tiered-cadence monitoring routine built on these five free trackers is a realistic, sustainable substitute for a paid GRC subscription — provided it is reviewed and re-scoped as the institution’s own AI use, partnerships and procurement expand.

  • Leiden Manifesto Checklist for Research Offices

    The Leiden Manifesto for Research Metrics sets out ten principles, published as a comment in Nature in 2015, for the responsible use of quantitative indicators in research evaluation. Research offices can convert each principle into a direct audit question, testing whether KPI dashboards, promotion criteria and grant-review rubrics rely on a single metric, ignore field norms, or substitute for qualitative judgement.

    The Leiden Manifesto for Research Metrics is a ten-principle framework for the responsible use of bibliometric and other quantitative indicators in evaluating research, published by Diana Hicks, Paul Wouters, Ludo Waltman, Sarah de Rijcke and Ismael Rafols in Nature on 22 April 2015. It was formulated at the 19th International Conference on Science and Technology Indicators, held in Leiden, the Netherlands, in September 2014, and has since been cited more than 4,000 times, according to Google Scholar’s tracking of the original paper.

    What is the Leiden Manifesto for Research Metrics?

    The Leiden Manifesto is a response to what its authors called “impact-factor obsession” — the tendency of universities, funders and promotion committees to substitute a single number for expert judgement. It does not ban metrics. It requires that quantitative indicators support, rather than replace, informed peer assessment of research quality.

    The manifesto’s home institution is the Centre for Science and Technology Studies (CWTS) at Leiden University, where co-author Paul Wouters served as director. CWTS also produces the CWTS Leiden Ranking, a separate bibliometrics-based university ranking — a distinction research offices should not conflate when citing the source.

    What are the ten principles of the Leiden Manifesto?

    Each principle addresses a specific failure mode observed in metric-driven research assessment. The table below states each principle exactly as published, alongside the practical audit question a research office should ask of its own KPI or promotion framework.

    # Principle (Hicks et al., 2015) Audit question for your office
    1 Quantitative evaluation should support qualitative, expert assessment Does any committee decision rest on a metric alone, with no narrative peer input?
    2 Measure performance against the research missions of the institution, group or researcher Are KPIs generic, or tailored to the unit’s stated mission (teaching-intensive, applied, translational)?
    3 Protect excellence in locally relevant research Does the framework penalise work published in non-English or regionally focused outlets?
    4 Keep data collection and analytical processes open, transparent and simple Can an academic reproduce their own score from publicly documented methodology?
    5 Allow those evaluated to verify data and analysis Is there a formal, timely route to challenge or correct metric data before a decision is made?
    6 Account for variation by field in publication and citation practices Are raw citation counts compared across disciplines without field normalisation?
    7 Base assessment of individual researchers on a qualitative judgement of their portfolio Does promotion criteria require a portfolio narrative, or just an h-index threshold?
    8 Avoid misplaced concreteness and false precision Are decimal-point differences in impact factor or citation rate treated as meaningful?
    9 Recognise the systemic effects of assessment and indicators Has the office assessed whether its KPIs create incentives to game submission counts or venues?
    10 Scrutinise indicators regularly and update them Is there a scheduled review cycle for the KPI framework itself, not just for scores against it?

    How can a research office audit its KPI and promotion framework against it?

    Running the manifesto as a live audit tool means working through each principle against real artefacts: the appraisal form, the promotion rubric, and the departmental dashboard.

    1. Mark every clause in the promotion/tenure criteria naming a specific metric (impact factor, h-index, citation count).
    2. Check each marked clause has a qualitative narrative requirement alongside it (Principles 1 and 7).
    3. Confirm KPI targets are set per unit mission, not copied institution-wide (Principle 2).
    4. Check non-English-language or applied outputs score on the same scale as high-impact-journal outputs (Principle 3).
    5. Verify each dashboard metric’s data source and calculation method is documented and accessible (Principles 4 and 5).
    6. Confirm citation indicators are field-normalised, not raw counts compared across disciplines (Principle 6).
    7. Look for false precision — ranking staff by two-decimal citation averages (Principle 8).
    8. Ask whether the KPI framework has driven any unintended behaviour, such as salami-slicing publications or discouraging risky research (Principle 9).
    9. Set a fixed review date for the framework itself, independent of individual appraisal cycles (Principle 10).

    A framework that fails more than two or three of these checks is not aligned with the manifesto, regardless of how sophisticated its dashboard software looks. The most common failure in practice is Principle 6: comparing raw citation counts across a mathematics department and a cell biology department, where top-ranked mathematics journals carry impact factors around 3 while top-ranked cell biology journals carry impact factors around 30 — a field-scale gap the manifesto’s authors cite directly as evidence that uncorrected cross-field comparison is meaningless.

    How does the Leiden Manifesto compare with DORA and CoARA?

    The Leiden Manifesto did not appear in isolation. The 2013 San Francisco Declaration on Research Assessment (DORA) preceded it, while the Coalition for Advancing Research Assessment (CoARA) has since built a sector-wide agreement on reforming assessment practice. Research offices are frequently asked which one to adopt.

    Framework Published Format Primary focus
    Leiden Manifesto 22 April 2015 (Nature comment) 10 principles Correct use of quantitative indicators across disciplines and settings
    DORA 2013 (San Francisco Declaration) General recommendations + signatory pledge Eliminating journal impact factor as a proxy for article or researcher quality
    CoARA 2022 (Agreement on Reforming Research Assessment) Institutional commitment agreement Sector-wide reform of hiring, promotion and funding assessment criteria

    DORA has been signed by more than 27,000 individuals and organisations, according to DORA’s own published tally as of March 2026, making it the higher-profile pledge. But when Loughborough University’s LIS-Bibliometrics committee chose a framework for its own policy in 2018, policy manager Elizabeth Gadd selected the Leiden Manifesto because it takes a “broader approach to the responsible use of all bibliometrics across a range of disciplines and settings” — not only journal-level metrics. Elsevier separately announced on 14 July 2020 that it would use the manifesto’s principles to guide its CiteScore methodology.

    In the UK, the independently commissioned Metric Tide review (2015), led by James Wilsdon for the then Higher Education Funding Council for England, reached compatible conclusions and recommended metrics support, not replace, peer review within the research administration processes underpinning the Research Excellence Framework. A research office building a REF-adjacent KPI policy should treat the two as aligned, not competing, references.

    Common questions and what comes next for research offices

    Who wrote the Leiden Manifesto for Research Metrics?

    The manifesto was written by Diana Hicks, professor of public policy at Georgia Institute of Technology, and Paul Wouters, then director of CWTS at Leiden University, together with co-authors Ludo Waltman, Sarah de Rijcke and Ismael Rafols. It was published as a comment in Nature, volume 520, on 22 April 2015.

    Does the Leiden Manifesto ban the use of bibliometrics tools?

    No. The manifesto does not prohibit bibliometrics tools such as Web of Science, Scopus or Dimensions. It requires that any output from these tools — citation counts, h-indices, journal metrics — be interpreted alongside qualitative expert review and adjusted for field-specific citation norms before it informs a decision.

    Why does the importance of bibliometrics remain contested?

    Bibliometrics matter because they scale evaluation across thousands of researchers where individual peer review is impractical. The contested part is misuse: treating a single indicator as an objective proxy for quality, rather than one input alongside portfolio review, mission fit and field context, as the manifesto’s ten principles specify.

    How often should a research office review its KPI framework under the manifesto?

    Principle 10 requires indicators to be “scrutinised regularly and updated,” but sets no fixed interval. Good institutional practice, reflected in library and research-office guidance built on the manifesto, is an annual technical review of data sources plus a full policy review on the same three-to-five-year cycle as promotion-criteria revisions.

    The Leiden Manifesto’s ten principles were written as durable evaluation ethics, not a one-time compliance exercise. As institutions layer AI-assisted analytics, altmetrics and funder-mandated open-data reporting onto existing KPI frameworks, the manifesto’s core requirement — that quantitative evaluation support, not replace, expert judgement — becomes harder to satisfy by default and more important to audit deliberately. Research offices that build the checklist above into their annual promotion-criteria review cycle, rather than treating the manifesto as background reading, are the ones actually applying it.

  • How to Link ORCID to Publications: 2 Methods

    Linking a publication to ORCID means associating your 16-digit ORCID iD with a specific work record — either automatically through a Crossref or DataCite metadata feed authorised when you submit a manuscript, or manually by entering a DOI, PubMed ID, or BibTeX file into the Works section of your ORCID record. Auto-updated works carry a materially stronger trust signal than self-asserted entries, because the claim originates from a third-party registration agency rather than the researcher.

    ORCID is a non-proprietary, persistent digital identifier that distinguishes individual researchers from one another and links them to their publications, datasets, funding, and institutional affiliations. Understanding how to link ORCID to publications correctly — and which method to use for which purpose — determines whether that record reads as verified evidence or as an unaudited self-report.

    What Linking a Publication to ORCID Actually Means

    An ORCID “Work” is any research output — a journal article, dataset, preprint, conference paper, or software release — attached to a researcher’s ORCID record. Each record can hold up to 10,000 works, a ceiling ORCID imposes to protect Registry performance, according to ORCID’s own support documentation.

    Every work carries a source: the entity that added it. That source field is the whole point. A work added by the researcher themselves is labelled with the researcher’s own name as source. A work added via an authorised integration — a publisher, Crossref, DataCite, or a research information system — is labelled with that organisation’s name as source. This single metadata field is what separates a verified claim from a self-report.

    How Auto-Update Works via Crossref and DataCite

    Auto-update is a “push” mechanism, not something a researcher does manually after the fact. It runs on trust relationships a researcher grants once and that then apply to every future publication. Publishers who register content with Crossref (for journal articles) or DataCite (for datasets and other outputs) can include an author’s ORCID iD in the deposited metadata.

    • Set-up: the researcher supplies their ORCID iD during manuscript or dataset submission and authorises the publisher as a “trusted organisation” on their ORCID record.
    • Trigger: when the work is registered and its DOI is minted, Crossref or DataCite passes the metadata, including the ORCID iD, back to the ORCID Registry.
    • Result: the work appears on the researcher’s ORCID record automatically, with the publisher or registration agency listed as the source — no manual entry required, then or ever again.

    ORCID’s own guidance favours this route: “Allowing trusted organizations to add information to your record ensures the data connected with your ORCID iD is authoritative and trustworthy,” per ORCID Support’s “Add works to your ORCID record” article. Auto-updated entries are visually flagged in the ORCID interface with a distinct icon next to the work.

    How Manual Import Works via DOI, PubMed ID, and BibTeX

    Manual import is a “pull” process the researcher initiates, typically to backfill a body of existing work that predates any auto-update authorisation. ORCID Support lists four routes, in addition to auto-update, from the Works section’s +Add menu:

    1. Import from other services — searching connected databases such as Web of Science, Scopus, or Crossref Metadata Search and bulk-importing matched records.
    2. Add work with a DOI — pasting a Digital Object Identifier, which pulls the full citation from the DOI registration agency.
    3. Add work with a PubMed ID — the same principle, using PMID for biomedical literature indexed in PubMed.
    4. Import a BibTeX file — exporting a library from Google Scholar, EndNote, or Mendeley to a .bib file and uploading it directly.
    5. Add work manually — typing citation details by hand for works with no identifier at all.

    Each route is initiated by the researcher and populates the record once, rather than on an ongoing basis. Identifier-based and BibTeX import draw on structured external metadata, so they are more reliable than fully manual entry, but the source field still reads as the researcher, not a registration agency, unless the import tool explicitly attributes the deposit.

    Auto-Update vs Manual Import: Which Carries More Trust?

    Both routes populate the same Works section, but they are not equivalent as provenance signals. The distinction that matters to institutions, funders, and research-integrity reviewers is who is asserting the claim, not how the citation data was formatted.

    Factor Auto-Update (Crossref/DataCite) Manual Import (DOI/BibTeX/Manual)
    Who initiates it Publisher, at registration/DOI-minting time Researcher, whenever they choose
    Recorded source Publisher or registration agency The researcher themselves
    Coverage Future works only, from authorisation onward Past and present works, added retrospectively
    Ongoing effort None after initial authorisation Repeated per work or per batch
    Trust signal Third-party verified Self-asserted

    An auto-updated work is corroborated by an external registration agency’s records — the kind of independently verifiable evidence that research assessment exercises and grant compliance checks look for. A manually entered work, even one anchored to a real DOI, still relies on the researcher’s own account linking “this person” to “this ORCID iD.” Institutions running authorship audits should treat the two categories differently, not as interchangeable Works-tab entries.

    The practical recommendation, and the one ORCID itself gives, is to use both: manual import to backfill the existing publication history, and auto-update authorisation with every future submission so new works never need re-entering.

    Frequently Asked Questions

    Can I use my ORCID iD for publications?

    Yes. An ORCID iD can be attached to any publication at submission, and most scholarly publishers now capture it as standard metadata. Once attached, that iD becomes the persistent link between the researcher and the work, regardless of name changes, institutional moves, or common-name ambiguity.

    How do I add an ORCID iD to a manuscript?

    Most journal submission systems prompt for an ORCID iD during author registration, then authenticate it via ORCID’s own sign-in flow. Once authorised, the publisher can include that iD in the metadata deposited with Crossref or DataCite when the article or dataset is registered and assigned a DOI.

    How do I link ORCID to a publisher such as Elsevier?

    Publisher platforms, including Elsevier’s Editorial Manager, typically show a “Use my ORCID” or “Connect ORCID” button during login or registration. Clicking it opens an ORCID authentication window; after signing in and authorising access, the publisher can read and, where permitted, write publication data to the record.

    What This Means for Institutions, Publishers, and Funders

    For research administrators, the auto-update versus manual-import distinction is not a technical footnote — it is a compliance and evidence question. UKRI’s Funding Service requires named investigators to supply an ORCID iD as part of grant applications, and institutions increasingly rely on ORCID’s Works data to populate REF-style outputs lists and funder reports. Data drawn from auto-updated, publisher-sourced Works entries is defensible evidence in that context; data drawn from unaudited manual entries is not, without further checking.

    This “who asserts the claim” logic underpins contributor-level attribution more broadly. CASRAI originated the CRediT contributor role taxonomy in 2014, and the standard is now stewarded by NISO as ANSI/NISO Z39.104-2022. CRediT statements and ORCID auto-updates share one design principle: attribution is more trustworthy when a party other than the researcher is on record as having made the claim. Institutions building publication-verification workflows, for CRediT contributor statements or ORCID Works alike, should apply the same provenance test.

    Publishers that deposit ORCID iDs with Crossref or DataCite at DOI registration are, in effect, running the infrastructure that makes auto-update possible at scale. Where that deposit step is skipped, researchers are pushed back onto manual import by default, regardless of preference.

    Conclusion: Building a Verifiable Publication Record

    Getting works onto an ORCID record is straightforward mechanically: import from a connected database, enter a DOI or PMID, upload a BibTeX file, or authorise auto-update at submission. The strategic choice is which of these to rely on for which purpose. Manual import is the right tool for backfilling a career’s worth of existing publications in one pass. Auto-update via Crossref and DataCite is the right tool for every submission from today onward, because it produces a record institutions, funders, and integrity reviewers can treat as third-party verified rather than self-reported. As research assessment increasingly leans on machine-readable provenance rather than researcher-supplied CVs, that distinction is likely to matter more, not less.

  • ORCID Membership: Consortium vs Direct Guide

    ORCID membership is free only for individual researchers; institutions that want to integrate ORCID into their systems must pay an organisational fee, either directly to ORCID Inc. or, at a discount, through a national or regional consortium. The choice between direct membership and consortium membership determines what an institution pays, which API scopes and integration support it gets, and whether it gains a voice in ORCID’s governance.

    ORCID membership is the paid organisational tier that lets an institution connect its own systems to the ORCID registry — reading and writing data to researcher records with permission — rather than simply relying on researchers’ free, individually held ORCID iDs.

    What is ORCID membership, and how is it different from free registration?

    Individual ORCID registration is, and always will be, free: any researcher can create a 16-digit ORCID iD at orcid.org/register in under a minute and use it for life. ORCID membership is a separate, paid tier for organisations — universities, publishers, funders, and service providers — that want to integrate ORCID data into their own institutional systems rather than rely on manual, researcher-entered information.

    Membership unlocks the ORCID Member API, which allows an institution’s research information system, repository or HR platform to read and, with the researcher’s permission, write data to the ORCID registry — publications, affiliations, grants and peer review activity. Without membership, an organisation can still search the public ORCID database and encourage “Sign in with ORCID” authentication, but it cannot programmatically update records at scale.

    ORCID Inc. reports more than 1,200 member organisations worldwide, made up of both direct members and institutions that joined through a consortium, spanning universities, publishers, funders, facilities and government agencies.

    What does direct institutional membership include?

    Direct membership means an institution contracts and pays ORCID Inc. directly, with no intermediary. Under ORCID’s published 2026 fee schedule, Basic direct membership costs US$4,775 a year for non-profit and government organisations (after a standard 20% non-profit discount) and US$5,975 for commercial organisations. Premium direct membership — which adds priority support, on-demand reporting and a customised onboarding — costs US$9,550 a year for smaller non-profit organisations (under US$200 million in annual revenue or funds) and rises to US$23,880 for larger non-profits above that threshold.

    Direct members manage their own ORCID integration: applying for membership, renewing annually, handling invoicing, and owning their API credentials without a consortium administrator in the loop. This suits institutions with in-house developer capacity that want a direct line to ORCID’s own support team and full control over procurement terms.

    • Standard application, renewal and invoicing handled directly with ORCID Inc.
    • Full Member API access to read and write ORCID record data with permission
    • Ability to negotiate specific procurement or legal requirements within ORCID’s standard framework
    • Additional integrations available at US$3,585 each per year

    What does consortium membership include, and how does it cut costs?

    Consortium membership is open only to non-profit and government organisations. A consortium lead — typically a national research infrastructure body — negotiates a single block agreement with ORCID and then apportions fees across member institutions, all of whom automatically receive Premium-equivalent access. In the UK, Jisc administers the national ORCID consortium, offering reduced membership costs plus UK-based technical and community support through a dedicated support site. Equivalent consortia operate elsewhere: the ORCID US Community is administered by Lyrasis, the Health Research Alliance runs a health-research-focused consortium with five premium API keys per member, and IReL administers the Irish Research eLibrary consortium.

    ORCID’s consortium fee table is tiered by both institutional budget size and the number of organisations in the consortium: a five-member consortium of small non-profits (under US$10 million annual budget) pays US$3,495 per member per year, falling to US$1,750 per member once the consortium reaches 60 or more members. Organisations in countries classified by the World Bank as Lower Income receive an 80% reduction on consortium fees, and Lower-Middle-Income organisations receive a 50% reduction, under ORCID’s Membership Equity Program — which also lowers the minimum consortium size from five to three organisations for a group’s first year.

    Consortium members gain two things direct members do not: a shared “community of practice” with peer institutions solving the same integration problems, and exclusive access to the Affiliation Manager tool, which lets non-technical staff add and update researcher affiliation data without a developer.

    Direct vs consortium: cost, API access and governance compared

    The headline trade-off is straightforward: consortium membership is cheaper and comes bundled with premium access and local support, but it hands administration to a third-party lead organisation; direct membership costs more but keeps the relationship — and the paperwork — entirely in-house.

    Factor Direct membership Consortium membership
    Who administers it ORCID Inc. directly A consortium lead (e.g. Jisc in the UK, Lyrasis for the ORCID US Community)
    2026 indicative cost US$4,775–US$23,880/year (non-profit, Basic to Premium) US$1,750–US$9,340/member/year, scaling down as consortium size grows
    Eligibility Any organisation type Non-profit and government organisations only
    API access level Basic or Premium (self-selected) Premium-equivalent, automatically
    Affiliation Manager tool Not included Included
    Local/community support ORCID’s own global support team Consortium lead’s national/regional support team
    Governance voice Eligible to stand for and vote in ORCID Board elections Eligible to stand for and vote in ORCID Board elections

    Institutional governance participation — nominating a representative for the ORCID Board and voting in annual Board elections — is a benefit of ORCID membership itself, not a differentiator between the two routes; both direct and consortium members hold this governance voice.

    Which route should an institution choose?

    For most universities and non-profit research organisations, joining an existing national or regional consortium is the more cost-effective starting point: it delivers premium API access, local implementation support and peer knowledge-sharing at a fraction of direct-membership pricing. Institutions in a country without an established consortium can use ORCID’s Membership Equity Program to form one with as few as three founding members in year one.

    Direct membership better suits organisations that are commercial (and therefore ineligible for a consortium), that need bespoke procurement or legal terms outside a consortium’s standard agreement, or that already run substantial in-house integration teams and prefer a direct relationship with ORCID’s support desk rather than a national intermediary.

    Research administration teams evaluating either route should confirm three things before signing: which access tier (Basic or Premium) the fee actually buys, whether a local consortium already exists for their jurisdiction, and whether their researcher information system vendor already holds member API credentials that could reduce the need for a separate institutional integration.

    Common questions about ORCID membership

    Does ORCID cost money?

    Individual ORCID registration is always free for researchers. Cost only applies at the organisational level: institutions pay an annual membership fee — starting around US$1,750 per member through a large consortium, or from roughly US$4,775 for direct non-profit membership — to integrate ORCID into their own systems.

    How much does it cost to register with ORCID?

    Registering for a personal ORCID iD costs nothing and takes under a minute at orcid.org/register. Institutional membership fees are separate and depend on the route chosen: direct membership is tiered by revenue, while consortium membership is tiered by both budget size and consortium membership count, per ORCID’s published 2026 fee schedule.

    What are the benefits of having institutional ORCID membership?

    Membership gives an institution Member API access to read and write trusted data — publications, affiliations, funding — directly into researcher ORCID records with permission, streamlining research information management, funder compliance reporting and automated CV generation for researchers.

    Implications for research administration

    As funders increasingly require ORCID iDs in grant applications and publishers embed them in submission workflows, institutional ORCID integration is shifting from optional to expected infrastructure. The consortium model has proven durable precisely because it converts a fixed, individually negotiated cost into a shared, scaling one — the more organisations that join a national consortium, the cheaper membership becomes for every existing member. Institutions weighing the decision should treat it as an infrastructure procurement choice tied to their research administration systems roadmap, not an isolated subscription decision.

  • Research Data Management Policy: Not Just a DMP

    A research data management policy is an institution-wide governance document that sets ownership, retention, storage and researcher-responsibility rules for all research data an organisation produces — distinct from a data management plan (DMP), which is a project-specific document written for a single grant. Confusing the two leaves institutions with fragmented practice: strong per-grant DMPs but no consistent rule for what happens to data once a project, or a researcher, moves on.

    A research data management policy is the institutional framework; the DMP is one project’s implementation of it. This article sets out the structural difference and gives a template for writing the institutional-level document, covering ownership, retention tiers, storage classes and researcher obligations.

    What is a research data management policy?

    A research data management (RDM) policy is a formally approved institutional document — typically ratified by a university executive, senate or research committee — that defines how all research data created, collected or reused at that institution must be handled across its lifecycle: creation, active use, retention, sharing and disposal.

    Unlike guidance notes or web pages, a policy carries institutional authority: it assigns accountability, sets minimum retention periods, and states what happens by default when a researcher leaves or a grant closes. The UKRI Concordat on Open Research Data (2016, updated 2020), signed by UK Research and Innovation, Universities UK and the Wellcome Trust among others, sets out common principles — including that research data are a public good and that costs of good data management are legitimate, fundable research costs. Most UK institutional RDM policies, including those at Edinburgh, Southampton and Manchester, cite the Concordat directly as their basis.

    Research data management policy vs a data management plan

    The policy and the DMP operate at different scopes and answer different questions. The policy answers “what does this institution require of everyone, always?” The DMP answers “how will this specific project handle its specific data?” A DMP written for a UKRI or Horizon Europe grant should reference and comply with the institutional policy, not substitute for it.

    Dimension Institutional RDM policy Data management plan (DMP)
    Scope Whole institution, all research Single project or grant
    Author Research office, library, IT, governance committee Principal investigator / research team
    Trigger Approved once, reviewed periodically Written at proposal stage, revised through project life
    Contains Ownership defaults, retention minimums, storage tiers, roles Dataset types, volumes, specific repositories, embargo dates
    Enforcement Institutional compliance / disciplinary framework Funder compliance check at reporting/audit
    Review cycle Every 3-5 years (Edinburgh’s policy specifies five) Reviewed and updated within the life of one project

    A well-run institution needs both, in that order: the policy first, so every subsequent DMP inherits a consistent set of defaults — retention minimums, approved repositories, data protection procedures — rather than each research team inventing its own.

    Template structure for an institutional RDM policy

    Reviewing current UK institutional policies (Edinburgh, Southampton, Manchester, Birmingham, Cambridge) shows a consistent structural skeleton. A new or revised policy should include, in order:

    • Purpose and scope — why the policy exists, and which staff, students and data types it covers.
    • Definition of research data — the institution’s own working definition (the UKRI Concordat’s is a common starting point: digital or analogue information collected, observed or created to validate research findings).
    • Roles and responsibilities — who is the data owner by default (usually the institution), who is the data steward (usually the principal investigator), and what the research office, IT services and library each provide.
    • Data management planning requirement — a mandate that a DMP must exist for every funded (and, ideally, every unfunded) research project, and where that requirement sits relative to ethics approval.
    • Storage and security tiers — approved storage classes mapped to data sensitivity.
    • Retention and disposal — minimum retention period, and the trigger for review or deletion.
    • Sharing, access and FAIR compliance — the institution’s default position on open data, exceptions for confidentiality, and adherence to the FAIR principles (Findable, Accessible, Interoperable, Reusable), as defined by Wilkinson et al. in Scientific Data (2016).
    • Legal and ethical compliance — UK GDPR and Data Protection Act 2018 obligations for personal data, plus any sector-specific requirements.
    • Review cycle and ownership of the policy itself — who revises it and how often.

    This ordering matters: policies that lead with storage and IT detail before establishing roles tend to read as IT documents rather than governance ones, which weakens researcher buy-in.

    Retention, ownership and storage tiers

    Retention should be set as a minimum, not a target. A commonly cited UK baseline is three years from project end or publication, with the caveat that funder, sponsor or disciplinary requirements specifying longer periods take precedence — clinical and health-related data, for example, routinely requires 10-15 year retention under separate regulatory regimes.

    Ownership defaults matter because researchers move institutions far more often than data does. Most UK institutional policies assign underlying ownership of research data to the institution as the legal entity that employed the researcher and typically held the grant, while the principal investigator retains stewardship responsibility — the practical duty of care — during and after the project. This split must be stated explicitly, not left implicit, because it is the clause institutions rely on when a departing researcher wants to take data with them.

    Storage tiers should be mapped to data sensitivity rather than treated as one undifferentiated pool. A workable minimum is three tiers:

    • Tier 1 — open/shareable: deposited in a Re3data-listed, CoreTrustSeal-certified repository with a DOI via DataCite.
    • Tier 2 — restricted/sensitive: access-controlled institutional storage under a data sharing agreement.
    • Tier 3 — confidential/personal: encrypted storage meeting UK GDPR requirements, with a Data Protection Impact Assessment on file.

    Researcher obligations and governance roles

    The policy should state researcher obligations as directives, not suggestions. At minimum, researchers are required to: complete a DMP before data collection begins; store active data only in institutionally approved systems; register externally held datasets with the institution; and provide a data access statement or citation in any publication when the underlying data are not directly deposited.

    Governance sits across three functions the policy must name individually: the research office (grant compliance, costing RDM into proposals — UKRI states that RDM costs are eligible under its funding), IT services (approved storage infrastructure and security), and the library or research data service (repository operation, metadata standards, researcher training). ARMA and INORMS provide sector benchmarking for how these research administration roles are typically distributed across institutions.

    Common questions

    What is the difference between a research data management policy and a data management plan?

    A research data management policy is an institution-wide governance document setting defaults for ownership, retention and storage. A data management plan is a project-specific document, usually required by a funder at proposal stage, that details how one project’s data will be collected, stored and shared within those institutional defaults.

    Who is responsible for research data management at an institution?

    Responsibility is shared but must be explicitly assigned. The principal investigator is typically the data steward for a given project; the institution holds underlying ownership; and the research office, IT services and library provide the supporting infrastructure, costing advice and repository services the policy commits to.

    How long should institutions retain research data?

    Most UK institutional policies set a minimum retention period of three years from project end or publication, deferring to longer funder-, sponsor- or discipline-specific requirements where they apply — for example, clinical research data typically requires substantially longer retention under separate regulatory regimes.

    What does FAIR data mean in a research data management policy?

    FAIR stands for Findable, Accessible, Interoperable and Reusable — principles defined by Wilkinson et al. (2016) that a policy should require researchers to apply when depositing data, typically through persistent identifiers, standard metadata and appropriate licensing. See the CASRAI research data dictionary for related term definitions.

    Implications for research administrators

    Institutions that only mandate DMPs at grant stage, without an underlying institutional policy, end up with inconsistent retention practice, ambiguous ownership when staff leave, and duplicated storage costs across departments running incompatible systems. Writing the institutional policy first — using the structure above — gives every subsequent DMP a consistent, auditable baseline, and gives research offices a defensible answer when a funder, ethics committee, or departing researcher asks who owns what and for how long.

    As RDM costs are increasingly built into grants and UK institutions face growing FOI and audit scrutiny of data retention, the institutional policy is the operational backbone that per-project DMPs are supposed to inherit from, not replace.

  • UKRI Open Access Block Grant: How It Works

    The UKRI open access block grant is an annual allocation UK Research and Innovation pays to eligible research organisations to help them meet the costs of complying with UKRI’s open access policy for research articles. It is not paid to individual researchers, and it is separate from — and administered differently to — the wider RCUK/Plan S open access mandate debate. This guide explains how the allocation is calculated, what it can and cannot fund, and what institutions must now report back to UKRI.

    A UKRI open access block grant is a lump-sum award, calculated from an institution’s UKRI-funded research volume, that research organisations distribute internally to cover open access publication costs rather than a grant researchers apply for directly.

    How is the UKRI block grant calculated and paid?

    UKRI does not divide a fixed pot equally between universities. Instead, the amount an organisation receives is calculated using an algorithm that uses directly incurred and directly allocated staff costs on UKRI awards as a proxy for research volume, according to UKRI’s own open access funding and reporting guidance. Institutions with a very small UKRI research footprint may receive nothing at all.

    For administrative reasons, only organisations whose calculated entitlement is £5,000 or more are offered an award. Every block grant allocated from 2022 onwards is published on UKRI’s Gateway to Research service, giving institutions and auditors a transparent, checkable record of what each organisation received and when.

    Payment is not a single annual cheque. Under the 2025–26 block grant terms and conditions, the grant covering 1 April 2025 to 31 March 2026 is paid via the EPSRC Research grants pay run process in four quarterly instalments, mirroring the cash-flow pattern of a standard research grant rather than a one-off subvention. UKRI’s own figures put total block grant spend at approximately £40 million per year across the research-article scheme, separate from the long-form publications fund described below.

    What can the block grant fund — and what can’t it fund?

    The block grant is deliberately flexible. Research organisations can spend it on any activity that supports compliance with UKRI’s open access policy, not just article processing charges (APCs). UKRI’s terms and conditions and the sector guidance built around them (for example Jisc’s publisher-facing compliance guide) converge on a consistent list of eligible and ineligible spend.

    • Eligible: APCs for fully open access journals and platforms.
    • Eligible: the “publish” element of Jisc-approved transitional (read-and-publish) agreements.
    • Eligible: membership or participation fees for alternative open access models, such as subscribe-to-open schemes.
    • Eligible: repository and green-route infrastructure costs, and staff time spent administering compliance, deposit checking and the block grant itself.
    • Not eligible: APCs for hybrid journals outside an approved transitional agreement.
    • Not eligible: page charges and colour charges.
    • Not eligible: long-form outputs — monographs, book chapters and edited collections sit under a separate, dedicated £3.5 million UKRI open access fund with its own caps (up to £10,000 for a book processing charge, £1,000 for a chapter processing charge, and £6,000 for participation in an alternative open access model, rising by a further £3,000 where an organisation has two or more eligible outputs in a period).

    Researchers cannot normally claim these costs directly from their research grant budget; the block grant exists precisely so that publication costs are pooled and administered centrally by the research organisation rather than budgeted line-by-line inside every award.

    How does UKRI’s grant compare with Wellcome, CRUK and BHF?

    Institutional open access teams frequently administer several funders’ block grants side by side, and confusion between them is a real, current problem. In particular, Cancer Research UK is winding down its own open access block grant from 1 April 2026, with a new CRUK policy taking effect on 1 October 2026 under which CRUK will no longer pay for open access publishing at all. That change concerns CRUK’s scheme only — it does not alter UKRI’s block grant, its eligibility rules or its payment schedule, though several university library guides bundle the funders together in ways that can make the two easy to conflate.

    Funder Scheme status (mid-2026) Hybrid journals covered? Repository deposit required?
    UKRI Ongoing annual block grant, ~£40m/year Only within Jisc-approved transitional agreements Europe PMC deposit required for MRC/BBSRC-funded articles
    Wellcome Ongoing; DOAJ-listed journals only No Europe PMC deposit required; rights retention statement required
    Cancer Research UK Ending — no APC funding after 1 October 2026 N/A (scheme closing) N/A
    British Heart Foundation Ongoing Yes, for original articles Europe PMC deposit required

    For research administrators, the practical takeaway is to treat each funder’s block grant as a distinct compliance stream with its own terms, rather than assuming a single institutional “open access fund” rulebook covers all of them.

    What are institutions’ reporting and assurance duties?

    Reporting obligations on the UKRI block grant have tightened materially for the 2026–27 cycle. Research organisations must already provide high-level information about their block grant spend through their Final Expenditure Statement, the same mechanism used for standard UKRI grant financial reporting, and block grant expenditure now falls within scope of UKRI’s Funding Assurance Reviews. Institutions need governance, financial and risk-management processes capable of demonstrating that funds were used for their intended purpose if selected for review.

    The most significant near-term change is that UKRI is reintroducing dedicated block grant reporting in 2026 to 2027 through a co-developed, lightweight, standardised template, explicitly designed to close evidence gaps around what institutions actually spend the money on. This marks a shift away from the lighter-touch, largely self-certified approach that has applied since the block grant scheme was last simplified, and research offices should expect to log spend by category (APCs, transitional agreements, repository costs, staff time) in a form that maps to that template rather than an internal ad hoc breakdown.

    1. Confirm which team owns block grant financial tracking (library, research office, or finance).
    2. Categorise 2026–27 spend against UKRI’s eligible-cost list as it is incurred, not retrospectively.
    3. Retain invoices and journal/agreement documentation in case of a Funding Assurance Review.
    4. Complete the Final Expenditure Statement and the new standardised reporting template on time.

    Answer-first Q&A

    What is the UKRI block grant policy?

    The UKRI open access block grant policy gives eligible UK research organisations an annual lump sum, sized to their UKRI-funded research volume, to cover eligible open access publication costs for research articles. It is administered by the institution, not claimed per-article from a researcher’s own grant.

    How is the UKRI block grant amount calculated?

    UKRI uses an algorithm based on directly incurred and directly allocated staff costs charged to UKRI awards as a proxy for an organisation’s research volume. Only organisations whose calculated entitlement reaches £5,000 or more are actually offered a grant.

    Do researchers apply for the UKRI block grant directly?

    No. Researchers do not apply to UKRI for block grant funding. The research organisation receives and administers the award, and individual authors instead request an APC payment or transitional-agreement cover through their own institution’s open access team.

    Do institutions have to report block grant spending to UKRI?

    Yes. Institutions must summarise spend through the Final Expenditure Statement, and block grants are now included within Funding Assurance Reviews. From 2026–27, a new standardised reporting template is being reintroduced specifically to capture more granular cost evidence.

    What this means for research administrators

    The direction of travel is towards more visibility, not less. A scheme that has run for over a decade on light-touch institutional discretion is moving into a period where UKRI wants comparable, standardised cost data across the sector. Institutions that build 2026–27 spend-tracking around UKRI’s eligible-cost categories now, rather than retrofitting records later, will find the reintroduced reporting template far less disruptive.

    Research administration teams should also keep the funder distinctions in this guide close at hand: UKRI’s own scheme continues on broadly the same basis it has run under since 2022, even as other funders in the same open access landscape — Cancer Research UK most visibly — withdraw block grant support altogether. Conflating the two risks under-claiming funding UKRI still provides, or over-promising APC cover a funder such as CRUK will no longer honour after October 2026.

  • What Is Research Governance? Beyond NHS Ethics

    Research governance is the institutional system of standards, delegated responsibilities and accountability mechanisms that ensures research is sponsored, conducted, resourced and reported to a consistent standard of quality and integrity — a system that spans sponsorship, data protection, financial probity and research integrity, not just the ethics approval most people associate with an NHS Research Ethics Committee.

    The phrase is frequently reduced, in searches and in institutional shorthand, to “getting NHS ethics sign-off.” That collapses a much wider accountability structure into a single procedural step. Research governance is the umbrella; ethics review is one component operating underneath it.

    What Is Research Governance?

    Research governance is the set of rules, standards and lines of accountability an institution puts in place to control how research is initiated, resourced, conducted and reported. NHS Research Scotland, whose remit covers governance across Scottish health boards, describes it as concerned with “setting standards to improve research quality and safeguard the public.” That is the safeguarding function. But governance is also an administrative control system: it determines who is legally and financially answerable when something goes wrong, long before any ethical question is raised.

    ARMA (the UK’s Association of Research Managers and Administrators) frames it more structurally, describing effective research governance as “the implementation of a fit-for-purpose decision-making framework under which an institution” operates. That decision-making framing matters: governance is not a checklist a researcher completes once. It is an ongoing institutional control system — the same category of function as financial governance or clinical governance, applied to the research enterprise.

    What Does Research Governance Actually Cover?

    A governance system that only covered ethics would be incomplete. In practice, institutional research governance operates across four interlocking strands, each with its own named accountable party and its own failure mode if neglected.

    • Sponsorship and legal accountability — the sponsor (usually the employing institution or funder) takes on the legal responsibility for a study’s initiation, management and financial arrangements, distinct from the researcher’s day-to-day conduct of it.
    • Data governance — how participant data, tissue samples and research datasets are collected, stored, shared and protected, governed alongside UK GDPR and institutional data protection policy.
    • Financial governance — probity in the use of grant and contract funds, adherence to funder terms and conditions, and audit trails for how public or charitable money was spent.
    • Research integrity — the honest conduct, reporting and attribution of research, including handling allegations of misconduct such as fabrication, falsification or plagiarism.

    Health and safety oversight and intellectual property management sit alongside these four strands in most institutional frameworks, particularly for laboratory-based or commercially exploitable research.

    Research Governance vs Research Ethics Review: What’s the Difference?

    Ethics review answers one question: is this specific study, as designed, ethically acceptable to run? Governance answers a broader one: does the institution have the systems in place to sponsor, resource, monitor and be accountable for research generally? A study can pass ethics review and still fail governance requirements — for example, if the sponsor has not confirmed indemnity and insurance arrangements, or if data-sharing agreements are not in place.

    Aspect Research Ethics Review Research Governance
    Core question Is this study design ethically acceptable? Can the institution be accountable for this research?
    Typical body Research Ethics Committee (REC) Sponsor, R&D office, research administration function
    Scope Participant welfare, consent, risk-benefit balance Sponsorship, data, finance, integrity, health & safety, IP
    Timing Pre-approval, one-off per protocol Continuous, across the study lifecycle
    Applies beyond NHS? Only where human participants/data/tissue are involved Yes — to all disciplines and funding types

    An institution’s own research administration function typically holds the governance oversight role, coordinating sponsor sign-off, data agreements and financial compliance across a study’s life, while the ethics committee’s involvement is generally concentrated at the design and approval stage.

    Who Is Responsible for Research Governance?

    Responsibility is distributed, not centralised in one office. The sponsor carries overall legal and financial accountability. The Chief Investigator is responsible for day-to-day conduct in line with the approved protocol. The employing institution provides the administrative infrastructure — contracts, insurance, data protection compliance — that makes sponsorship possible. Funders, including UK Research and Innovation (UKRI), attach their own governance conditions through grant terms and conditions, requiring institutions to demonstrate integrity and financial-probity safeguards as a condition of funding.

    Under international clinical trial standards such as ICH Good Clinical Practice (ICH-GCP), sponsor obligations are made explicit and legally binding — a level of formality that has increasingly influenced how non-clinical research governance is structured, even where GCP itself does not strictly apply.

    What Frameworks Define Research Governance in the UK?

    The UK’s foundational document was the 2005 Research Governance Framework for Health and Social Care, issued separately by the four UK nations. The Health Research Authority (HRA) subsequently consolidated these into a single UK-wide document — the UK Policy Framework for Health and Social Care Research — which, per the HRA’s own record, replaced “the separate Research Governance Frameworks in each UK country with a single, modern set of principles for the whole UK,” co-developed with the health departments of Northern Ireland, Scotland and Wales. The HRA’s published record shows this framework was most recently updated on 10 January 2025, reflecting a living document rather than a static one.

    Beyond health research, the Concordat to Support Research Integrity — developed under the auspices of Universities UK — sets out institutional commitments to rigour, transparency, accountability and support for researchers across all disciplines, not solely clinical fields. Attribution and authorship disputes, a recurring integrity concern under governance, connect to contributorship standards such as the CRediT taxonomy, which CASRAI originated in 2014 and which is now stewarded as ANSI/NISO Z39.104-2022 — a reminder that even a narrow-looking standard can sit inside a much larger governance accountability chain.

    Common Questions About Research Governance

    Why is research governance important?

    Research governance is important because it protects participants, safeguards public and funder trust, and creates a clear accountability chain when something goes wrong — financially, ethically or scientifically. Without it, institutions have no defined mechanism for assigning responsibility across sponsors, investigators and funders, increasing legal and reputational exposure.

    Is research governance the same as clinical governance?

    No. Clinical governance covers the quality and safety of patient care delivery within a healthcare organisation, while research governance covers the conduct, sponsorship and accountability of research activity itself. They overlap in NHS settings but apply to different organisational functions and different named accountable roles.

    What is a sponsor in research governance?

    A sponsor is the organisation — typically the employing institution, a university, or a funder — that takes on legal responsibility for confirming a study is properly designed, resourced, insured and managed before it begins. The sponsor role is distinct from the researcher’s role and cannot be left undefined.

    Does research governance apply outside the NHS?

    Yes. Research governance applies across all disciplines — social sciences, engineering, humanities and commercially funded research — wherever an institution sponsors, funds or hosts a research activity, not only where NHS patients, tissue or data are involved.

    Implications and Outlook

    For institutional leaders, the practical implication is structural: governance cannot be delegated entirely to an ethics committee, nor treated as a one-time approval gate. It requires standing infrastructure — a research administration function capable of tracking sponsorship status, data agreements, financial compliance and integrity casework concurrently, across every live project, not just those with NHS involvement.

    As funders including UKRI tie funding conditions more tightly to demonstrable integrity and financial-probity safeguards, and as the HRA continues to revise the UK Policy Framework, institutions that treat governance as an accountability system — rather than an ethics-approval formality — will be better positioned to withstand funder audits, data protection scrutiny and misconduct investigations alike.

  • Retraction Watch Database: Hiring Due Diligence

    The Retraction Watch Database (RWDB) lets research offices, tenure committees and funders check whether a candidate’s published papers carry a retraction, correction or expression of concern. Used properly — combined with author, affiliation, article-type or date-range search fields, cross-checked against ORI case summaries, and read for the stated reason rather than the bare fact of a hit — it becomes a genuine due-diligence tool rather than a source of false alarms.

    The Retraction Watch Database is a free, searchable index of scholarly retractions, corrections and expressions of concern, built by the Center for Scientific Integrity and distributed with Crossref. It is the largest curated source of retraction metadata available, but it indexes withdrawn papers, not people — why due diligence needs more than a name search.

    What Is the Retraction Watch Database, Exactly?

    RWDB is a structured dataset, not a blog archive: each entry records the original article, the notice, the stated reason, and the author/affiliation strings as printed on the paper. As of mid-2026 it logs more than 65,000 retraction entries. Crossref took on distribution in 2023, publishing the full CSV through a public repository rather than only the web form — the hosted interface at retractiondatabase.org suits one-off lookups; the download suits batch screening.

    Critically, RWDB does not aim for completeness on corrections and expressions of concern the way it does for retractions. Its own user guide states EOCs and corrections are entered mainly “as they relate to existing retractions, blog posts, or high-profile studies” — a clean result there is not evidence of a clean record.

    Search by author name first, narrow by affiliation, then confirm with PMID or DOI. Since 23 October 2024, RWDB has required every search to include at least one of: Article Type(s), an Original Paper date range, a Retraction/Notice date range, or a PMID/DOI — a blank author-only search no longer works, a change most existing search guidance predates.

    • Author field: try name variants and the wildcard (*), e.g. *doe*, since journals list authors inconsistently.
    • Affiliation field: free text only, matched against the original journal’s wording, not a normalised list.
    • Article Type / date range: now mandatory as a search anchor; pair a rough employment period with the author name.
    • PMID or DOI: the most precise route once a specific paper is identified.

    Each search returns a maximum of 50 rows on screen, with a banner showing the true total — worth noting when a prolific or common-named candidate returns more hits than the interface displays.

    What Counts as a Genuine Red Flag Versus a False Positive?

    A retraction hit is a prompt to investigate, not a finding of misconduct. RWDB’s reason-code taxonomy (Appendix B of the user guide) separates honest error, authorship disputes and duplicate publication from deliberate fabrication — only the latter is relevant to a fitness assessment.

    Signal Likely false positive Likely genuine concern
    Author role Middle/minor co-author, no data or analysis role First, corresponding, or last author
    Reason code Honest error, journal-initiated editorial correction Data fabrication, image manipulation, plagiarism
    Pattern Single isolated retraction across a long career Multiple retractions clustered in a short period
    Notice type Correction or expression of concern only Formal retraction with a stated integrity reason

    A 2025 study via Taylor & Francis, indexed on PubMed, found metadata discrepancies between RWDB, PubMed and Web of Science for the same retracted articles — reason to cross-reference a second source before treating any record as final. RWDB also standardises the author field to “Editorial Staff” on journal-initiated notices, never to be misread as identifying the candidate.

    Paper mills add a layer: outputs typically cluster by template, image reuse or tortured phrasing across unrelated author groups, a pattern the COPE–STM Paper Mills investigation has documented since 2022. A retracted paper matching paper-mill characteristics warrants closer scrutiny than an isolated retraction.

    How Does RWDB Compare With ORI Research Misconduct Case Summaries?

    RWDB and US Office of Research Integrity (ORI) case summaries answer different questions, and due diligence needs both. RWDB tells you whether a paper was withdrawn; ORI tells you whether a person was found, after federal investigation, to have committed misconduct — even where no retraction followed.

    Feature Retraction Watch Database ORI case summaries
    Unit of record A published article/notice A named individual with a misconduct finding
    Scope Global, all disciplines and publishers US Public Health Service-funded research only
    Trigger for entry A retraction, correction, or notable EOC is published A formal ORI investigation concludes with a finding
    Typical gap Misses misconduct with no resulting retraction Misses retractions outside PHS-funded, US-linked research

    Because ORI findings can precede, follow, or occur without a retraction, checking RWDB alone misses candidates sanctioned through supervision requirements or funding debarment whose flawed papers were never withdrawn. Hiring, tenure or funding decisions should run both checks, not treat either as a substitute.

    What Does a Due-Diligence Screening Workflow Look Like in Practice?

    1. Confirm identity anchors — collect name variants, ORCID iD, and known affiliations before searching.
    2. Run the RWDB author search with a date range or article-type anchor as required, using wildcards for name variants.
    3. Filter to retractions specifically — the default result mixes in corrections and expressions of concern, which are not comprehensively indexed.
    4. Read the reason code for every hit rather than counting hits; separate honest error from fabrication, plagiarism, or image manipulation.
    5. Check ORI case summaries for the same name, independently, to catch misconduct findings with no associated retraction.
    6. Cross-reference a second metadata source (PubMed, Web of Science) before any hit informs a decision.
    7. Document the process and allow a response — record which fields were searched and on what date, and give the candidate an opportunity to explain any substantive finding before it affects the outcome.

    Answer-First Q&A on Retraction Screening

    What is the Retraction Watch Database?

    The Retraction Watch Database is a free, searchable index of scholarly retractions, corrections and expressions of concern, distributed with Crossref. It records over 65,000 retraction entries with metadata on authors, journals, dates and stated reasons — but it indexes withdrawn papers, not verified findings against individuals.

    Do retracted studies still get cited?

    Yes. Citation-tracking studies confirm retracted papers continue to be cited after the retraction notice is published, often because citing authors are unaware of it. This is one reason due-diligence checks cannot rely on citation counts as a proxy for integrity.

    What is the purpose of Retraction Watch?

    Retraction Watch exists to track and report retractions as a window into how science self-corrects, publishing the underlying blog since 2010 and the structured database since 2018. Its purpose is transparency, not adjudicating misconduct — that sits with journals, institutions, and bodies such as ORI.

    How do you check for retractions on a specific paper or author?

    Search RWDB’s author or affiliation fields, or enter the paper’s PMID or DOI directly for the most precise match. Since October 2024 the search also requires an article-type or date-range anchor, so pair an author name with an approximate publication period.

    What Are the Implications for Research Offices and Funders?

    Institutions that skip a structured check within their research administration due-diligence process risk reputational and funding harm they could otherwise catch before an offer is made. Treating a single retraction hit as automatic disqualification risks penalising honest-error corrections with no integrity finding — both failure modes are avoidable with a documented, two-source workflow.

    Authorship transparency makes this more tractable: contributor-role frameworks such as CRediT — originated by CASRAI in 2014 and now stewarded by NISO as ANSI/NISO Z39.104-2022 — let a research office consult authorship and contribution records to see whether a flagged co-author actually held a data-generating or analytical role, rather than a minor one, sharpening the false-positive filter above.

    Where Is Misconduct Screening Heading Next?

    Expect due-diligence practice to keep converging on multi-source verification rather than any single registry. As paper-mill detection tooling matures and Crossref’s stewardship of RWDB deepens, the advantage will sit with research offices that build a repeatable, documented workflow now — spanning RWDB, ORI case summaries, and contributor-role verification — rather than an ad hoc name search at the point of hire.

  • Has cOAlition S Retreated From Plan S Rules?

    cOAlition S has not abandoned the goal of full and immediate open access, but its 2026-2030 strategy drops the enforcement mechanism that made Plan S distinctive: financial support for transformative agreements ended after 2024, replaced by a looser, consultation-led push toward diamond open access and preprints. Science.org’s reporting calls this a retreat from strict requirements; cOAlition S calls it a “recalibration” of the same founding mission. Both are partly right, and research administrators deciding how much weight to put on the new targets need to understand exactly what changed.

    Plan S is the funder mandate, launched in September 2018 by cOAlition S, requiring that publications from publicly funded research be made immediately available under an open licence, without embargo, from 2021 onward. cOAlition S is the consortium of national and philanthropic research funders — including UKRI and the Wellcome Trust — that created and enforces that mandate.

    What Does the 2026-2030 Strategy Actually Change?

    The cOAlition S Strategy 2026-2030, adopted by the coalition’s Leaders Group in November 2025, keeps the founding commitment to full and immediate open access but widens the toolkit for getting there. Where the original Plan S centred on a single lever — funder mandates tied to compliance checks — the new strategy explicitly states that “no single model can meet all needs” and extends its focus “beyond mandates and funding conditions.”

    Three priorities anchor the plan: strengthening the foundations for sustainable and equitable open access (including an update to the Plan S principles to foreground Publish-Review-Curate models, diamond open access and preprints); supporting open digital infrastructures, including work on artificial intelligence’s implications for scholarly publishing; and exploring financially sustainable, non-APC publishing systems. Implementation runs in two phases — foundational work in 2026-2027, followed by a deeper equity and sustainability push in 2028-2030, subject to Leaders Group review.

    Why Does Science.org Call This a Retreat?

    Science.org’s analysis, headlined “After Coalition S disrupted scientific publishing, new plan retreats from strict requirements,” argues the new strategy has no teeth. Its central claim: cOAlition S is trading enforceable compliance rules for a broader, softer vision that favours alternatives to paywalled journals without committing to actually replace them.

    The magazine credits the original Plan S with helping push the global share of newly published papers appearing as open access above 50% within a few years of the 2021 mandate taking effect. But it also revisits a well-documented side effect: Plan S’s compliance route pushed many publishers toward author-pays gold and hybrid open access, and some prestigious journals now charge authors thousands of dollars per article while continuing to publish paywalled content elsewhere in the same title. A commentary from Science’s news desk on social media put the critique concisely: the latest strategy “emphasizes consultation, but lacks spending pledges.”

    • No new mandate deadlines are attached to the 2026-2030 priorities.
    • No enforcement or compliance-checking mechanism replaces the one built around transformative agreements.
    • Financial commitments are framed as exploratory (“investigate,” “monitor”) rather than binding.

    How Does cOAlition S Defend the New Strategy?

    cOAlition S rejects the framing of “retreat” outright. Its own communications describe the strategy as reinforcing, not loosening, its open access commitment, under a refreshed vision of “a scholarly communication system that enables rapid, open, transparent, and equitable sharing of trustworthy scientific knowledge.”

    The coalition points to concrete institution-building as evidence of continuity rather than disengagement: it appointed Curt Rice — former rector of Oslo Metropolitan University and the Norwegian University of Life Sciences, and former Executive Director of Fulbright Norway — as its first standing Director, announced 13 May 2026, specifically to lead delivery of the 2026-2030 strategy. It has also named OPERAS, the European research infrastructure for open scholarly communication, as its new Host Secretariat, and it co-produced the Bengaluru Roadmap and Action Plan on Diamond Open Access at the 3rd Global Summit on Diamond Open Access. None of that reads as an organisation stepping back — it reads as one restructuring around a different theory of change: build sustainable, non-commercial infrastructure rather than police compliance.

    What Happens to Transformative Agreements?

    Transformative agreements — the “read and publish” deals between institutions and publishers designed to convert subscription spend into open access output — are the clearest casualty of the shift. cOAlition S confirmed the end of its financial support for open access publishing under transformative arrangements after 2024, having already stopped accepting new applications to the programme after 30 June 2023.

    In their place, the 2026-2030 strategy channels investment toward diamond open access — journals and platforms that charge neither authors nor readers — and toward preprint infrastructure. Diamond open access is a publishing model funded through institutional, library-consortium or public grants rather than per-article charges, positioned by cOAlition S as the more equitable long-term alternative to both subscription paywalls and high-cost APCs.

    Mechanism Status under Plan S (2018-2024) Status under 2026-2030 strategy
    Transformative agreements Funded as a transitional route to compliance Funding ended after 2024; no new applications since June 2023
    Diamond open access Encouraged, not prioritised Named strategic priority, backed by the Bengaluru Roadmap
    Compliance mandate Immediate OA required from 2021, checked via the Journal Checker Tool Principles retained, but no new binding deadlines set
    Governance Coordinated informally among funders Standing Director (Curt Rice) and OPERAS-hosted Secretariat

    Answer-First Questions on Plan S and cOAlition S

    What Is Plan S?

    Plan S is a funder-led initiative, launched in September 2018, requiring that publications resulting from publicly funded research be published in open-access journals, on open-access platforms, or deposited in open repositories immediately, without embargo. It is supported by cOAlition S, an international consortium of national and philanthropic research funders.

    What Is the Main Principle of Plan S?

    The core principle is that, from 2021, all scholarly publications funded by public or private grants from participating funders must be made immediately available in open access, without embargo, under an open licence — typically CC BY. That mandate remains unchanged in the 2026-2030 strategy; what has changed is how compliance is supported.

    Is Open Access Always Free for Everyone?

    No. Open access guarantees free reading access, not free publishing. Under the author-pays model that expanded alongside Plan S compliance, many journals shifted costs onto authors through article processing charges, which critics — including Science.org — argue created a new equity problem the 2026-2030 strategy now explicitly tries to address through diamond open access.

    What Does This Mean for Institutions and Publishers?

    For research administrators and institutional leaders, the practical takeaway is that Plan S’s headline compliance requirement has not disappeared — the Journal Checker Tool still governs how researchers assess eligible venues — but the financial pressure that pushed publishers into transformative agreements has been withdrawn. Institutions currently relying on transformative deals negotiated with cOAlition S funding in mind should not assume renewal on the same terms.

    Publishers, meanwhile, face a genuine strategic fork: continue investing in APC-based hybrid and gold open access, where cOAlition S funding is no longer available, or build toward diamond and Publish-Review-Curate models that better match the coalition’s stated 2028-2030 priorities. Institutions tracking funder mandates and compliance timelines through their research administration functions will find this shift material to budget planning, not just messaging.

    Neither “retreat” nor “recalibration” fully settles the argument. Science.org is correct that the new strategy carries no new enforcement mechanism and no fresh spending pledge. cOAlition S is correct that its founding mandate — immediate, unembargoed open access — has not been withdrawn on paper. The honest reading sits between the two: cOAlition S has traded a narrower, harder lever for a broader, softer one, betting that infrastructure and diamond open access will do the work that compliance deadlines used to do. Whether that bet pays off will be visible well before 2030, in whether diamond open access funding actually scales and whether APC inflation slows without a mandate forcing the issue.